Sucralfate and Oxetacaine Oral Suspension

Experience rapid relief from ulcer pain and gastric irritation with this dual-action oral suspension. Combining Sucralfate (1 g/5 ml) and Oxetacaine (10 mg/5 ml), it forms a physical protective barrier over delicate ulcerated stomach tissue while delivering local anesthetic relief to instantly soothe burning sensations. Ideal for the management of gastric and duodenal ulcers, gastritis, and reflux-related discomfort.

Sucralfate and Oxetacaine Oral Suspension is a gastrointestinal pharmaceutical formulation designed to help relieve pain and discomfort associated with acid-related disorders of the stomach and upper digestive tract. It combines Sucralfate, a mucosal protective agent, with Oxetacaine (also known as Oxethazaine), a local anaesthetic that helps reduce pain and burning sensations. Sucralfate works by forming a protective coating over damaged or irritated areas of the stomach and duodenal lining, helping shield the affected tissues from gastric acid, pepsin, and other irritating substances while supporting the natural healing process. Oxetacaine provides local anaesthetic action by reducing the transmission of pain signals from the affected mucosal surface, helping relieve symptoms such as epigastric burning, acidity-related discomfort, and pain associated with certain acid-related gastrointestinal conditions. Together, these ingredients provide complementary protective and symptomatic effects and may be prescribed for conditions such as peptic ulcer disease, gastritis, and other selected disorders involving irritation of the upper gastrointestinal tract, depending on the diagnosis and approved product indications. The oral suspension dosage form offers a convenient option for patients who have difficulty swallowing tablets and allows administration according to the prescribed regimen. Possible side effects may include constipation, nausea, dry mouth, or gastrointestinal discomfort. Sucralfate can interfere with the absorption of certain oral medicines, so appropriate spacing between doses may be necessary. Patients with kidney impairment should consult a healthcare professional before use because Sucralfate contains aluminium. The exact ingredient strengths and pack size should be verified from the product label, as formulations vary between manufacturers. Sucralfate and Oxetacaine Oral Suspension should be used under appropriate medical supervision, and persistent abdominal pain, difficulty swallowing, vomiting blood, or black stools require prompt medical evaluation rather than continued self-treatment.